20 results
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Antimicrobial Treatment ... Microorganisms Causing Native ... Osteomyelitis #management ... #treatment #pharmacology ... #idsa
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
Guideline for the Management ... Task Force on Clinical ... America #HFrEF #HeartFailure ... #Management #CHF ... #treatment #algorithm
Candidemia Workup and Management - IDSA Guidelines
1) Antibiotics
 • Empiric: Echinocandins (e.g. micafungin) for most patients
Candidemia Workup and Management ... - IDSA Guidelines ... Susceptibilities, Negative ... or TEE unless clinical ... #candidiasis #treatment
Cor triatriatum
 • Epidemiology
 • Etiology
 • Associated Lesions
 • Differentials Diagnosis
 • Anatomy - Sinister,
Associated Lesions • Differentials ... Physiology • Clinical ... Diagnosis • Treatment ... Post-Operative Management ... #cardiology #summary
Selected Oral Antibacterial Agents With Excellent Oral Bioavailability Commonly Used to Treat Patients With Native Vertebral
Patients With Native ... Osteomyelitis #management ... #treatment #pharmacology ... #idsa
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... HIV-AIDS Preventing Clinical ... Trypanosomiasis #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
have achieved negative ... #diagnosis #differential ... #algorithm #management ... #cardiology #treatment ... #pharmacology
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... #CHF #sCHF #HeartFailure ... #HFrEF #Pharmacology ... #Management #Treatment ... #StageC #Cardiology
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... evidence, and relative ... Tuberculosis #MDRTB #management ... #pharmacology # ... ebm #idsa
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
Fraction (HFrEF) Clinical ... endomyocardial biopsy Pharmacology ... Jcortesizaguirr #HFrEF #heartfailure ... #diagnosis #management ... #cardiology #pharmacology